Bone Matrix Graft Products Linked to Tuberculosis Risks, FDA Warns
The FDA is calling for more stringent screening of bone matrix tissue donors in light of repeated tuberculosis outbreaks among bone graft patients
Tag Archives: Bone Implant
-
-
FDA Issues Letter To Doctors About Issues with NuVasive Precice Limb-Lengthening Devices
Prior warnings and recalls of the limb-lengthening implants have raised concerns about biocompatibility problems, leading the FDA to warn doctors to remove the devices after one year.
-
Mechanical Failures, Biocompatibility Problems with NuVasive MAGEC System Implants Lead To FDA Warning
-
FDA Warns of Biocompatibility Risks With NuVasive Specialized Orthopedics’ Precice devices
